Some clinical and pharmacological studies have confirmed the link between GPCR signaling and insulin receptor cascade activation by ANG II, in which ANG II infusion is known to induce insulin resistance, and ANG II converting enzyme inhibitors (ACE) inhibitors and AT1R blockers improve insulin sensitivity [20]. This evidence concerns the gene ACE and Insulin resistance.